These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7450031)

  • 1. [Research on a compound with psychotropic activity. V - a new derivative of pyrrolo[2,1-d][1,5]benzothiazepin-6,6-dioxide: synthesis and sedative activity].
    Nacci V; Fiorini I; Corti P; Taddei I; Bernabei F; Fratiglioni P
    Farmaco Sci; 1980 Apr; 35(4):279-97. PubMed ID: 7450031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compounds with psychotropic activity. VIII. Synthesis and sedative activity of various 9-substituted derivatives of 5-phenylpyrrolo[2,1-d][1,5] benzothiazepine and cis-4,5-dihydro-4-hydroxy-5-phenylpyrrolo[2,1-d][1,5]benzothiazepine].
    Nacci V; Fiorini I; Vomero S; Taddei I; Taddei E
    Farmaco Sci; 1984 Apr; 39(4):289-304. PubMed ID: 6723946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research on compounds with psychotropic activity. II. Synthesis of 5-phenylpyrrolo-(2,1-d)-benzothiazepin-6,6-dioxide and 1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo-(2,1-d) (1,5)-benzo-thiazepin-1,4-dione-6,6-dioxide derivatives and their pharmacological properties].
    Nacci V; Filacchioni G; Porretta GC; Stefancich G; Guaitani A
    Farmaco Sci; 1973 Jun; 28(6):494-510. PubMed ID: 4716500
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on compounds with psychotropic activity. I. Synthesis of 5-phenylpyrrolo-(2,1-d)(1,5)-benzothiazepin-6,6-dioxide and 1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo-(2,1-d)(1,5)-benzothiazepin-1,4-dione-6,6-dioxide, derivatives of a new heterocyclic system].
    Nacci V; Filacchioni G; Porretta GC
    Farmaco Sci; 1972 Nov; 27(11):1003-17. PubMed ID: 4647184
    [No Abstract]   [Full Text] [Related]  

  • 5. Research on compounds with psychotropic activity. IX--Synthesis of 6-p-methoxyphenylpyrrolo[2,1-d][1,5]benzothiazepines and evaluation of their affinities for BDZ and GABA receptor subtypes.
    Nacci V; Fiorini I; Garofalo A; Cagnotto A
    Farmaco; 1990 May; 45(5):545-58. PubMed ID: 2171544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase.
    Di Santo R; Costi R
    Farmaco; 2005 May; 60(5):385-92. PubMed ID: 15910811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile.
    Menegatti R; Silva GM; Zapata-Sudo G; Raimundo JM; Sudo RT; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2006 Feb; 14(3):632-40. PubMed ID: 16198114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
    Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
    Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
    Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of 4-alkoxy-2-[2-hydroxy-3-(4-o,m,p-halogenoaryl-1 -piperazinyl)propyl]-6-methyl-1H-pyrrolo-[3,4-c]pyridine-1,3(2H)-diones with analgesic and sedative activities.
    Sladowska H; Sabiniarz A; Szkatuła D; Filipek B; Sapa J
    Acta Pol Pharm; 2006; 63(4):245-54. PubMed ID: 17203859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible psychopharmacological agents. Part 3: Synthesis and CNS activity of some new fluorine-containing pyrazolo[3,4-e][1,4]thiazepines.
    Joshi KC; Dubey K
    Pharmazie; 1979 Nov; 34(11):716-8. PubMed ID: 545339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F; O'Halloran A; Kelly JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1456-63. PubMed ID: 17706334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological study of 5,6,8,9-tetrahydro-4H, 7H-pyrrolo[1,2-a]cyclopenta[b]thieno[3,2-f][1,4]diazepines.
    Vega S; Gil MS; Darias V; Sanchez Mateo CC; Exposito MA
    Pharmazie; 1995 Jan; 50(1):27-33. PubMed ID: 7886122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for antidepressant, sedative and analgesic activities of novel fused thiophene derivatives.
    Wardakhan WW; Abdel-Salam OM; Elmegeed GA
    Acta Pharm; 2008 Mar; 58(1):1-14. PubMed ID: 18337204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant activity of new hetero[2,1]benzothiazepine derivatives.
    Vega S; Diaz JA; Darias V; Sanchez Mateo CC; Albertos LM
    Pharmazie; 1998 Feb; 53(2):130-4. PubMed ID: 9540110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.
    Hattesohl M; Feistel B; Sievers H; Lehnfeld R; Hegger M; Winterhoff H
    Phytomedicine; 2008 Jan; 15(1-2):2-15. PubMed ID: 18160026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.